Anthony P. Fernandez MD, PhD
Assistant Professor of Clinical Medicine, Cleveland Clinic Lerner College of Medicine; Co-Medical Director of Continuing Medical Education, Director of Medical Dermatology, W.D. Steck Chair of Clinical Dermatology, and Staff Physician, Dermatology and Pathology, Cleveland Clinic, Cleveland, OhioAnthony P. Fernandez, MD, PhD, completed his dermatology residency at the University of Miami, Florida and a dermatopathology fellowship at the Cleveland Clinic. He is currently a staff physician at the Cleveland Clinic in Cleveland, Ohio where he practices both medical dermatology and dermatopathology and serves as Director of medical and inpatient dermatology and the W.D. Steck Chair of Clinical Dermatology. He is also Co-Medical Director of Continuing Medical Education at the Cleveland Clinic and Assistant Professor of Clinical Medicine at the Cleveland Clinic Lerner College of Medicine.
Clinically, he specializes in treatment of systemic autoimmune and inflammatory diseases with prominent cutaneous involvement. His research interests mirror his clinical interests, with ongoing projects involving psoriasis, dermatomyositis, lupus erythematosus, cutaneous vasculitis and pemphigus vulgaris. He is also active in a variety of national professional organizations, such as the American Academy of Dermatology, the Americans Society of Dermatopathology, and the Rheumatologic Dermatology Society. He currently serves on the editorial board for the Journal of the American Academy of Dermatology and Healio’s Dermatology and Psoriasis Peer Perspective Boards.
Disclosures
Abbvie speaker and consultant
Recent Contributions to PracticeUpdate:
- Association Between Treatment With Biologics and Cardiovascular Comorbidities in Patients With Psoriasis
- Rapid Improvement in Skin Pain Severity and Its Impact on Quality of Life in Adult Patients With Moderate to Severe Atopic Dermatitis
- Effect of Dermatologic Consultation on Survival in Patients With Checkpoint Inhibitor Associated Cutaneous Toxicity
- Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis
- Long-Term Outcomes of Rituximab Therapy in Pemphigus
- Perioperative Management of Pyoderma Gangrenosum
- Coronary Artery Plaque Characteristics and Treatment With Biologic Therapy in Severe Psoriasis
- Coronary Artery Plaque Characteristics and Treatment With Biologic Therapy in Severe Psoriasis
- Up to 90% Hailey-Hailey Disease Improvement With Low-Dose Naltrexone
- Low-Dose Naltrexone for Hailey-Hailey Disease